Article

Transcriptome profiling of cerebrospinal fluid in Alzheimer’s Disease reveals molecular dysregulations associated with disease

2023-11-22

Abstract excerpt

<h4>ABSTRACT</h4> Despite the increasing prevalence of neurodegenerative diseases, the molecular characterization of the brain remains challenging due to limited access to the tissue. Cerebrospinal fluid (CSF) contains a significant proportion of molecular contents originating from the brain, and characterizing these molecules has served as a surrogate to evaluate molecular dysregulation in the brain. Here we perf...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bf772b85-f751-573f-9137-cfe24b1febb9
DOI: 10.1101/2023.11.21.23298852

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Transcriptome profiling of cerebrospinal fluid in Alzheimer’s Disease reveals molecular dysregulations associated with diseaseDOI 10.1101/2023.11.21.23298852Read

Comparative transcriptomics of choroid plexus in Alzheimer’s disease, frontotemporal dementia and Huntington’s disease: implications for CSF homeostasisSemantic proximity Read

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseSemantic proximity Read

Alzheimer’s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionSemantic proximity Read

Exploratory Single-Cell RNA Sequencing of Peripheral Blood Identifies Candidate Signatures Associated with Alzheimer’s DiseaseSemantic proximity Read

Assess Alzheimer’s Disease via Plasma Extracellular Vesicle-derived mRNASemantic proximity Read

Whole transcriptome RNA-Seq reveals drivers of pathological dysfunction in a transgenic model of Alzheimer’s diseaseSemantic proximity Read

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseSemantic proximity Read

Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profilesSemantic proximity Read

An RNA biomarker panel for the diagnosis of Alzheimer’s disease from whole bloodSemantic proximity Read

Transcriptomics in Alzheimer’s Disease: Aspects and ChallengesSemantic proximity Read

Cytokine expression profile in the human brain of older adultsSemantic proximity Read

CSF-Seq enables transcriptome-wide profiling of cerebrospinal fluid and identifies prognostic signature of leptomeningeal diseaseSemantic proximity Read